Location History:
- Brighton, MA (US) (1990 - 1995)
- North Andover, MA (US) (1995 - 2010)
Company Filing History:
4 out of 16 
3 out of 6 
2 out of 16,338 
Years Active: 1990-2010
Title: Walter P. Carney: Innovator in Cancer Monitoring Technologies
Introduction
Walter P. Carney is a notable inventor based in Brighton, MA (US), recognized for his significant contributions to cancer patient monitoring technologies. With a total of 13 patents to his name, Carney has developed innovative methods that enhance the understanding and treatment of cancer.
Latest Patents
Among his latest patents, Carney has introduced assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples. This invention describes clinically important methods for examining and monitoring cancer patients undergoing treatment. By measuring levels of analytes such as uPA, PAI-1, and their complex, healthcare providers can assess disease progression and treatment effectiveness. Another significant patent focuses on monitoring the extracellular domain (ECD) of the epidermal growth factor receptor (EGFR) in cancer patients. This method allows for the evaluation of treatment outcomes by comparing ECD levels in patients to those in normal control individuals.
Career Highlights
Carney has worked with prominent companies in the biotechnology field, including Oncogene Science, Inc. and Applied Bio Technology. His work has been instrumental in advancing cancer research and improving patient care through innovative diagnostic methods.
Collaborations
Throughout his career, Carney has collaborated with esteemed colleagues such as Sara J. McKenzie and Robert Allan Weinberg, contributing to the development of groundbreaking cancer monitoring technologies.
Conclusion
Walter P. Carney's innovative work in cancer patient monitoring has made a significant impact on the field of oncology. His patents reflect a commitment to improving patient outcomes through advanced diagnostic methods.